Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure

AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastroenterol
Glavni autori: Theodorakis, Nicholas G, Wang, Yining N, Korshunov, Vyacheslav A, Maluccio, Mary A, Skill, Nicholas J
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2015
Teme:
Basic Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/
https://ncbi.nlm.nih.gov/pubmed/25892862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items